Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine.
Medise BE, Soedjatmiko S, Rengganis I, Gunardi H, Sekartini R, Koesno S, Satari HI, Hadinegoro SR, Yang JS, Excler JL, Sahastrabuddhe S, Puspita M, Sari RM, Bachtiar NS. Medise BE, et al. Among authors: soedjatmiko s. PLoS One. 2019 Feb 13;14(2):e0211784. doi: 10.1371/journal.pone.0211784. eCollection 2019. PLoS One. 2019. PMID: 30759132 Free PMC article. Clinical Trial.
One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine.
Medise BE, Soedjatmiko S, Gunardi H, Sekartini R, Satari HI, Hadinegoro SR, Wirahmadi A, Puspita M, Sari RM, Yang JS, Sil A, Sahastrabuddhe S, Bachtiar NS. Medise BE, et al. Among authors: soedjatmiko s. Int J Infect Dis. 2020 Apr;93:102-107. doi: 10.1016/j.ijid.2020.01.045. Epub 2020 Jan 28. Int J Infect Dis. 2020. PMID: 32004693 Free article. Clinical Trial.
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report.
Medise BE, Soedjatmiko S, Gunardi H, Sekartini R, Satari HI, Hadinegoro SR, Wirahmadi A, Puspita M, Sari RM, Yang JS, Sil A, Sahastrabuddhe S, Bachtiar NS. Medise BE, et al. Among authors: soedjatmiko s. BMC Pediatr. 2020 Oct 15;20(1):480. doi: 10.1186/s12887-020-02375-4. BMC Pediatr. 2020. PMID: 33059607 Free PMC article. Clinical Trial.
Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children.
Prayitno A, Taurel AF, Nealon J, Satari HI, Karyanti MR, Sekartini R, Soedjatmiko S, Gunardi H, Medise BE, Sasmono RT, Simmerman JM, Bouckenooghe A, Hadinegoro SR. Prayitno A, et al. Among authors: soedjatmiko s. PLoS Negl Trop Dis. 2017 Jun 15;11(6):e0005621. doi: 10.1371/journal.pntd.0005621. eCollection 2017 Jun. PLoS Negl Trop Dis. 2017. PMID: 28617803 Free PMC article.
Educational videos to address vaccine hesitancy in childhood immunization.
Lubis TA, Gunardi H, Herqutanto, Soedjatmiko S, Satari HI, Alatas FS, Pulungan AB. Lubis TA, et al. Among authors: soedjatmiko s. Vaccine. 2022 Sep 29;40(41):5965-5970. doi: 10.1016/j.vaccine.2022.08.044. Epub 2022 Sep 6. Vaccine. 2022. PMID: 36085255 Free PMC article.
Correction: Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children.
Prayitno A, Taurel AF, Nealon J, Satari HI, Karyanti MR, Sekartini R, Soedjatmiko S, Gunardi H, Medise BE, Sasmono RT, Simmerman JM, Bouckenooghe A, Hadinegoro SR. Prayitno A, et al. Among authors: soedjatmiko s. PLoS Negl Trop Dis. 2018 May 2;12(5):e0006467. doi: 10.1371/journal.pntd.0006467. eCollection 2018 May. PLoS Negl Trop Dis. 2018. PMID: 29718914 Free PMC article.